-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 DlQMWp0x0fkWj7uQYvDT/mdx4rB3vLx6NvEfVJuvS2AbrijLjY3QP3XeVUPtmALz
 7tPioZfLtPhWbM48NYv1BA==

<SEC-DOCUMENT>/in/edgar/work/20000810/0000920148-00-000045/0000920148-00-000045.txt : 20000921
<SEC-HEADER>0000920148-00-000045.hdr.sgml : 20000921
ACCESSION NUMBER:		0000920148-00-000045
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20000801
ITEM INFORMATION:		
ITEM INFORMATION:		
FILED AS OF DATE:		20000810

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LABORATORY CORP OF AMERICA HOLDINGS
		CENTRAL INDEX KEY:			0000920148
		STANDARD INDUSTRIAL CLASSIFICATION:	 [8071
]		IRS NUMBER:				133757370
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231
</COMPANY-DATA>

		FILING VALUES:
			FORM TYPE:		8-K
			SEC ACT:		
			SEC FILE NUMBER:	001-11353
			FILM NUMBER:		690335
</FILING-VALUES>

			BUSINESS ADDRESS:	
				STREET 1:		358 S MAIN ST
				STREET 2:		4225 EXECUTIVE SQ STE 800
				CITY:			BURLINGTON
				STATE:			NC
				ZIP:			27215
				BUSINESS PHONE:		3362291127
</BUSINESS-ADDRESS>

				MAIL ADDRESS:	
					STREET 1:		358 S MAIN ST
					STREET 2:		4225 EXECUTIVE SQ SUITE 800
					CITY:			BURLINGTON
					STATE:			NC
					ZIP:			27215
</MAIL-ADDRESS>

					FORMER COMPANY:	
						FORMER CONFORMED NAME:	NATIONAL HEALTH LABORATORIES HOLDINGS INC
						DATE OF NAME CHANGE:	19940314
</FORMER-COMPANY>
</FILER>
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>0001.txt
<TEXT>




      UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                   WASHINGTON, D.C. 20549

                          FORM 8-K

                       CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange
Act of 1934
                       AUGUST 1, 2000
                     ------------------
              (Date of earliest event reported)


         LABORATORY CORPORATION OF AMERICA HOLDINGS
         ------------------------------------------
   (Exact name of registrant as specified in its charter)


   DELAWARE                1-11353             13-3757370
 --------------          -----------         --------------
(State or other         (Commission         (IRS Employer
jurisdiction of         File Number)         Identification
incorporation)                                    Number)


   358 SOUTH MAIN STREET, BURLINGTON, NORTH CAROLINA 27215
   -------------------------------------------------------
          (Address of principal executive offices)

                        336-229-1127
                        ------------
    (Registrant's telephone number, including area code)


<PAGE>

ITEM 5. OTHER EVENTS

  On  August  1,  2000, Laboratory Corporation  of  America-
Registered Trademark-Holdings (LabCorp-Registered Trademark-
)  announced  that it has completed the acquisition  of  Los
Angeles-based  National  Genetics  Institute,  Inc.   (NGI).
Terms of the stock purchase transaction were not disclosed.

ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL
        INFORMATION AND EXHIBITS

 (c)  Exhibit
      20  Press release of the Company dated
          August 1, 2000.


<PAGE>
                         SIGNATURES

Pursuant to the requirements of the Securities and Exchange
Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned hereunto duly
authorized.

          LABORATORY CORPORATION OF AMERICA HOLDINGS
          ------------------------------------------
                         (Registrant)

               By: /s/BRADFORD T. SMITH
                  ------------------------------
                      Bradford T. Smith
                      Executive Vice President,
                      General Counsel, Secretary
                      and Compliance Officer



Date: August 9, 2000

<PAGE>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-20
<SEQUENCE>2
<FILENAME>0002.txt
<TEXT>

Laboratory Corporation of America-Registered Trademark- Holdings
358 South Main Street
Burlington, NC   27215
Telephone:  336-584-5171


FOR IMMEDIATE RELEASE
- ---------------------

Contact:  336-436-4855                  Shareholder Direct: 800-LAB-0401
          Pamela Sherry                                     www.labcorp.com


  LABORATORY CORPORATION OF AMERICA-REGISTERED TRADEMARK- COMPLETES
             ACQUISITION OF NATIONAL GENETICS INSTITUTE


Burlington, NC, August 1, 2000 - Laboratory Corporation of America-
Registered Trademark- Holdings (LabCorp-Registered Trademark-) (NYSE:
LH) today announced that it has completed the acquisition of Los
Angeles-based National Genetics Institute, Inc. (NGI).  Terms of the
stock purchase transaction were not disclosed.

"We are delighted to add the preeminent hepatitis C testing
laboratory to our industry-leading molecular diagnostic services,"
said Thomas P. Mac Mahon, chairman and chief executive officer of
LabCorp.  "Molecular diagnostics are the future of laboratory
testing, and we intend to leverage NGI's unique ultra-sensitive
testing tools to accelerate our leadership position in genomics.  NGI
is also a very important strategic and operational addition to
LabCorp's national testing capabilities, immediately providing us
with a premier West Coast molecular testing facility."

The Company noted that each of the above forward-looking statements
is subject to change based on various important factors, including
without limitation, competitive actions in the marketplace and
adverse actions of governmental and other third-party payors.
Further information on potential factors that could affect the
Company's financial results is included in the Company's Form 10-K
for the year ended December 31, 1999 and subsequent SEC filings.

Laboratory Corporation of America-Registered Trademark- Holdings
(LabCorp-Registered Trademark-) is a national clinical laboratory
with annual revenues of $1.7 billion in 1999.  With 18,000 employees
and over 100,000 clients nationwide, the company offers more than
2,000 clinical tests ranging from simple blood analyses to
sophisticated molecular diagnostics. LabCorp leverages its expertise
in innovative clinical testing technology with three Centers of
Excellence. The Center for Molecular Biology and Pathology, in
Research Triangle Park (RTP), North Carolina, develops applications
for polymerase chain reaction (PCR) technology. Its Center for
Occupational Testing in RTP is one of the world's largest substance
abuse testing facilities, and the Center for Esoteric Testing in
Burlington, North Carolina, performs the largest volume of specialty
testing in the network.  LabCorp's clients include physicians, state
and federal government, managed care organizations, hospitals,
clinics, pharmaceutical and Fortune 1000 companies, and other
clinical laboratories.

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
